receptor inhibition adenylate cyclase human ventricular myocardium BACKGROUND Receptors couple stimulatory protein Gs cyclase positive inotropic response human heart contrast receptors receptor cyclase inhibitory protein Gi negative inotropic response Activation Gi-coupled receptors heart failure Furthermore alpha Gi human ventricular myocardium inhibitory receptor cyclase METHODS RESULTS receptor inhibition adenylate cyclase crude particulate preparations nonfailing human ventricles Experimental conditions maximal inhibitory responses Dose-response curves selective receptor agonist R-phenylisopropyl-adenosine R-PIA differences versus heart basal adenylate cyclase activity versus pmol cyclic AMP/min/mg maximal R-PIA-mediated inhibition versus pmol cyclic AMP/min/mg R-PIA versus slope versus Furthermore forskolin manganese adenylate cyclase activation different heart consistent change catalytic unit adenylate cyclase inhibitory protein alpha Gi pertussis toxin-catalyzed ADP-ribosylation heart versus optical density units Basal adenylate cyclase activity heart versus pmol cyclic AMP/min/mg assay conditions protein effects CONCLUSIONS receptor pathway major inhibitory effect human myocardial adenylate cyclase activity alpha Gi heart receptor inhibition adenylate cyclase preparations versus human ventricular myocardium 